DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Andreone P, Colombo MG, Enejosa JV. et al.
ABT-450, ritonavir, ombitasvir, and dasabuvir achieves 97% and 100% sustained virologic response with or without ribavirin in treatment-experienced patients with HCV genotype 1b infection.
Gastroenterology 2014;
147: 359-365 e351
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.